Increased understanding of the SARS-CoV-2 virus to immediately identify targets for the use of already approved drugs and, in the medium term, to develop new ones. They will characterize the partial structure and dynamics of three proteins and three peptides of SARS-CoV-2 in order to identify in the short term the therapeutic targets on which to use already approved drugs and, in the medium term, to develop new drugs.
Principal Investigators: Douglas Vinson Laurents (IQFR), Miguel Mompeán (IQFR)
ISCIII COV20_00764
